Needle-Free Drug Injection Systems - Global Strategic Business Report

  • ID: 2228052
  • Report
  • Region: Global
  • 183 Pages
  • Global Industry Analysts, Inc
1 of 4

FEATURED COMPANIES

  • AKRA Dermojet (France)
  • Crossject SA (France)
  • PharmaJet (USA)
  • Zogenix, Inc. (USA)
  • MORE
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Needle-Free Drug Injection Systems in US$ Million.

Company profiles are primarily based on public domain information including company URLs.

The report profiles 62 companies including many key and niche players such as:
  • AKRA Dermojet
  • Crossject SA
  • DAntonio Consultants International, Inc.
  • Medical International Technologies, Inc.
  • National Medical Products, Inc.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AKRA Dermojet (France)
  • Crossject SA (France)
  • PharmaJet (USA)
  • Zogenix, Inc. (USA)
  • MORE

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Needle-Free Drug Injection Systems: An Overview
Needle-Free Drug Delivery Systems: An Overview
Brief Glance of Needle-Free Drug Delivery Systems
Advantages
Disadvantages
Needle-Free Drug Injection System: Market Dynamics
Drivers and Barriers of Needle-free Drug Injection Systems Market
Increasing Geriatric Population to Drive Market
Table 1: Global Aging Population (in Thousands) by Age Group: 1975, 2000 & 2025P (includes corresponding Graph/Chart)
Table 2: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
Table 3: Life Expectancy for Select Countries in Number of Years (2015) (includes corresponding Graph/Chart)
Improving Healthcare Expenditure to Foster Growth
Table 4: Healthcare Spending as % of GDP by Region (2016) ( includes corresponding Graph/Chart)
Table 5: Healthcare Spending as a Percentage of GDP in Select Countries (2013) (includes corresponding Graph/Chart)
Table 6: Per-Capita Healthcare Spending in US$ for Select Countries (2013) (includes corresponding Graph/Chart)
Increasing Incidence of Cancer Bodes Well for Needle-free Drug Injection Systems
Global Cancer Prevalence Statistics
Opportunity Indicators
Table 7: Worldwide Incidence of Cancer (2012, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
Table 8: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 9: New Cancer Cases in the World in Thousands by Affected Site (2012) (includes corresponding Graph/Chart)
Expanding Therapeutic Applications to Generate Growth Opportunities
Competitive Scenario
Needle-free Jet Injections: Future Burning Bright
Growth Factors
Next Generation Needle-free Jet Technologies
Advantageous to Different Stakeholders
Applications
Formulation Challenges
Current Development Status
The Road Ahead
Innovations in Needle-Free Drug Injection System Technology
Needle-free Arterial Non-Injectable Connector
Pulsed Micro Jets

2. FUTURE APPLICATIONS
Inactivated Polio Vaccine
Influenza Vaccine
Measles-Mumps-Rubella Vaccine
BCG Vaccine
Yellow Fever Vaccine
E. DTP-Hib-hep B Vaccine
Rabies Vaccine
Insulin Therapy
Others

3. DRUG DELIVERY SYSTEMS
AN OVERVIEW
Oral Vaccines
Nasal Sprays, Suppositories and Eye and Nose Drops
Inhalers
Select Vaccine Inhalers in Development Stage (2016)
Transdermal
Injected Fine Mist or Powder
Jet Injectors
Iontophoretic Transdermal
Patches
Microneedles
Implants

4. PRODUCT OVERVIEW

5. RECENT INDUSTRY ACTIVITY
PharmaJet® Adds Trivalent and Quadrivalent Influenza Vaccine to Injector System
Eternity Healthcare’s Lenis® Device Bags CE Certification
PharmaJet® Inks Deal With Serum Institute to Launch Needle- free MMR Vaccine
Inovio Pharmaceuticals Acquires BioJect Medical Technologies
PharmaJet® Partners With Vaccibody for HPV Vaccine Development
Zika Virus DNA Vaccine Clinical Trial Being Conducted With PharmaJet Needle-free Device
PharmaJet Inks Partnership Agreement with Distributors for Marketing PharmaJet® Across the US
Antares Pharma Bags FDA Approval for ZOMACTON™ and ZOMAJet™
Portal Instruments Raises US$25 million in Series B Financing
West Pharmaceutical Services Bags 510(k) Clearance for Needle-stickGuards
Crossject Develops Needle-Free Injection System
The ZENEO Device
FDA Grants Approval for Stratis Needle-Free Injection System
Portal Instruments® Raises US$11 million from Sanofi

6. FOCUS ON SELECT PLAYERS
AKRA Dermojet (France)
Crossject SA (France)
D’Antonio Consultants International, Inc. (USA)
Medical International Technologies, Inc. (Canada)
National Medical Products, Inc. (USA)
PharmaJet (USA)
Zogenix, Inc. (USA)

7. GLOBAL MARKET PERSPECTIVE
Table 10: World Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 11: World Historic Review for Needle-Free Drug Injection Systems by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 12: World 14-Year Perspective for Needle-Free Drug Injection Systems by Geographic Region
Percentage Breakdown of Dollar Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Market Overview
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 13: US Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 14: US Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Market Overview
Strategic Corporate Development
Medical International Technologies, Inc.
A Key Canadian Player
B.Market Analytics
Table 15: Canadian Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 16: Canadian Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. JAPAN
Market Analysis
Table 17: Japanese Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 18: Japanese Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. EUROPE
Market Analysis
Table 19: European Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region
France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 20: European Historic Review for Needle-Free Drug Injection Systems by Geographic Region
France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 21: European 14-Year Perspective for Needle-Free Drug Injection Systems by Geographic Region
Percentage Breakdown of Dollar Revenues for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE
A.Market Analysis
Market Overview
Strategic Corporate Development
Select Players
B.Market Analytics
Table 22: French Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 23: French Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4b. GERMANY
Market Analysis
Table 24: German Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 25: German Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4c. ITALY
Market Analysis
Table 26: Italian Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 27: Italian Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4d. UNITED KINGDOM
Market Analysis
Table 28: UK Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 29: UK Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4e. SPAIN
Market Analysis
Table 30: Spanish Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 31: Spanish Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4f. RUSSIA
Market Analysis
Table 32: Russian Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 33: Russian Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4g. REST OF EUROPE
Market Analysis
Table 34: Rest of Europe Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 35: Rest of Europe Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
Market Analysis
Table 36: Asia-Pacific Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 37: Asia-Pacific Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6. LATIN AMERICA
Market Analysis
Table 38: Latin American Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 39: Latin American Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

7. REST OF WORLD
Market Analysis
Table 40: Rest of World Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 41: Rest of World Historic Review for Needle-Free Drug Injection Systems Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 62 (including Divisions/Subsidiaries 67)

  • The United States (33)
  • Canada (5)
  • Japan (2)
  • Europe (13)
    • France (3)
    • Germany (2)
    • The United Kingdom (4)
    • Rest of Europe (4)
  • Asia-Pacific (Excluding Japan) (14)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AKRA Dermojet (France)
  • Crossject SA (France)
  • D’Antonio Consultants International, Inc. (USA)
  • Medical International Technologies, Inc. (Canada)
  • National Medical Products, Inc. (USA)
  • PharmaJet (USA)
  • Zogenix, Inc. (USA)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll